| F012 | C1-Esterase Inhibitor | |
| F218 | HEPATITIS B CORE ANTIBODY TOTAL | |
| f218 | HEPATITIS B CORE ANTIBODY IGM | |
| F158 | HEPATITIS B SURFACE ANTIBODY QUALITATIVE | |
| F155 | HEPATITS B SURFACE ANTIGEN | |
| F153 | HEPATITS A ANTIBODY TOTAL | |
| F150 | Hepatitis A Antibody IGM | |
| E100 | Protein Electrophoresis Serum | |
| L170 | LAMOTRIGINE | |
| L410 | TACROLIMUS | |
| E144 | Mycoplasma Antibodies | |
| E758 | ALDOSTERONE/RENIN ACTIVITY RATIO | |
| L856 | ZINC, SERUM OR PLASMA | |
| E759 | ALDOSTERONE | |
| U001 | APOLIPOPROTEIN E (APOE) 2 MUTATIONS | |
| F530 | CALPROTECTIN | |
| E532 | FATTY ACIDS PROFILE ESSENTIAL (C12-C22) | |
| E380 | LIPOPROTEIN A | |
| F162 | PARVO B19 IGM | |
| F161 | PARVO B19 IGG ABS | |
| L893 | OPIATES SERUM OR PLASMA QUANTITATIVE | |
| E439 | FREE T4 BY EQUILIBRIUM DIALYSIS | |
| F802 | THYROGLOBULIN BY LC-MS/MS SERUM OR PLASMA | |
| L405 | SIROLIMUS BY TANDEM MASS SPECTROMETRY | |
| E842 | Metanephrines, Fractionated, 24hour | |
